Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Interest & Investment Income (2016 - 2025)

iBio (IBIO) has disclosed Interest & Investment Income for 16 consecutive years, with $493000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 340.18% to $493000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $911000.0, a 65.04% increase, with the full-year FY2025 number at $437000.0, up 20.39% from a year prior.
  • Interest & Investment Income was $493000.0 for Q4 2025 at iBio, up from $267000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $493000.0 in Q4 2025 to a low of -$43000.0 in Q2 2021.
  • A 5-year average of $102950.0 and a median of $60500.0 in 2022 define the central range for Interest & Investment Income.
  • Biggest YoY gain for Interest & Investment Income was 3700.0% in 2021; the steepest drop was 1533.33% in 2021.
  • iBio's Interest & Investment Income stood at $35000.0 in 2021, then rose by 17.14% to $41000.0 in 2022, then increased by 2.44% to $42000.0 in 2023, then surged by 166.67% to $112000.0 in 2024, then skyrocketed by 340.18% to $493000.0 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Interest & Investment Income are $493000.0 (Q4 2025), $267000.0 (Q3 2025), and $79000.0 (Q2 2025).